Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Mustang Bio Receives Positive Listing Determination from Nasdaq GlobeNewswire - Tue Nov 12, 7:30AM CST

MBIO : 0.2200 (-3.64%)
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma GlobeNewswire - Thu Nov 7, 7:30AM CST

MBIO : 0.2200 (-3.64%)
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds GlobeNewswire - Thu Oct 24, 1:10PM CDT

MBIO : 0.2200 (-3.64%)
Biotech Advances Propel Oncology Market to $564.5B Amid Youth Cancer Spike Newswire.ca - Thu Jun 20, 4:26PM CDT

/CNW/ -- USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer...

ONCY : 0.9950 (+1.53%)
ONC.TO : 1.39 (+0.72%)
MBIO : 0.2200 (-3.64%)
LEGN : 37.42 (-2.02%)
JNJ : 154.77 (+0.50%)
NRIX : 21.79 (-4.93%)
Oncology Market Rising Towards $564.5B Amid Cancer Spike and Biotech Innovations BayStreet.ca - Thu Jun 20, 2:18PM CDT

VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before....

ONCY : 0.9950 (+1.53%)
ONC.TO : 1.39 (+0.72%)
MBIO : 0.2200 (-3.64%)
LEGN : 37.42 (-2.02%)
JNJ : 154.77 (+0.50%)
NRIX : 21.79 (-4.93%)
Mustang Bio Announces Updated Interim Data on X-Linked Severe Combined Immunodeficiency Treatment with Lentiviral Vector Gene Therapy Support Upcoming Multicenter Pivotal Phase 2 Trial for MB-107 Globe Newswire - Thu May 19, 2022

All 23 treated patients are alive at 2.6-year median follow-up without evidence of malignant transformation Data representing largest cohort of infants...

MBIO : 0.2200 (-3.64%)
Mustang Bio Reports First Quarter 2022 Financial Results and Recent Corporate Highlights Globe Newswire - Thu May 12, 2022

Data from two programs selected for oral presentations at the upcoming American Society of Gene & Cell Therapy 25th Annual Meeting and the European...

MBIO : 0.2200 (-3.64%)
Mustang Bio Announces Results from Follicular Lymphoma Cohort of Ongoing Phase 1/2 Clinical Trial of MB-106, CD20-Targeted CAR T Therapy, Selected for Oral Presentation at European Hematology Association 2022 Hybrid Congress Globe Newswire - Thu May 12, 2022

Favorable safety profile, high overall response and complete response rates, and CAR T persistence observed in patients with relapsed or refractory...

MBIO : 0.2200 (-3.64%)
Mustang Bio Announces Data on Treatment with Lentiviral Viral Vector Gene Therapy for X-Linked Severe Combined Immunodeficiency Selected for Oral Presentation at American Society of Gene & Cell Therapy 25th Annual Meeting Globe Newswire - Tue May 3, 2022

Data represent largest cohort of infants with XSCID, also known as bubble boy disease, who received lentiviral gene therapy with the longest follow-up to...

MBIO : 0.2200 (-3.64%)
Mustang Bio Announces Upcoming MB-106 CD20-Targeted CAR T Data Presentations Globe Newswire - Thu Apr 21, 2022

Fred Hutch’s Dr. Mazyar Shadman to present data on Mustang’s autologous CAR T-cell therapy for the treatment of B-cell non-Hodgkin lymphomas and chronic...

MBIO : 0.2200 (-3.64%)

Barchart Exclusives

Is It Time to Buy This Dividend Stock With Nuclear Energy Upside? Barchart - Mon Nov 18, 6:30PM CST
Apart from its prowess in nuclear energy, this energy company is also deploying AI. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot